Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
The role of PRC2 and H3K27 methylation in eNOS repression
FY 2008-09
Summary
Dysregulated repressive transcriptional mechanisms can alter endothelial cell (EC)-specific gene expression in ECs and non-ECs to possibly cause disease states. Abnormal EC-specific gene expression might cause vasculogenic mimicry, a phenomenon in which aggressive melanoma cells adopt an "EC-like" phenotype to siphon blood flow to itself. Hypoxia (<1% O2) elicits endothelial dysfunction, in part, by transcriptionally repressing eNOS, an EC-specific gene. Deeper understanding of the repressive mechanisms regulating EC-specific gene expression can improve our therapeutic potential against such disease states. Our lab (the Marsden Lab)has found that the EC-specific expression of eNOS is regulated by epigenetic pathways associated with transcription activation, such as histone acetlyation and histone H3K4 methylation, and transcription repression, such as DNA methylation. Interestingly, our studies on eNOS epigenetic repression in non-expressing human aortic vascular smooth muscle cells (AoVSMCs) and chronically hypoxic (24 hours) human umbilical vein endothelial cells (HUVECS) suggest that it is regulated by additional repressive mechanisms. We hypothesize that histone H3K27 methylation and its mediator, polycomb repressive complex 2 (PRC2), epigenetically silence eNOS in non-expressing AoVSMCs and chronically hypoxic ECs. To test this, we will determine if histone H3K27 methylation and PRC2 subunits, such as the Ezh2 H3K27 methyltransferase, are enriched at the eNOS promoter in AoVSMCs and chronically hypoxic HUVECs by conducting chromatin immunoprecipitation assays. If AoVSMCs and chronically hypoxic HUVECs are enriched with trimethylated H3K27 and Ezh2 at the eNOS promoter, Ezh2 will be depleted by siRNA in these cells and eNOS transcriptional activity will be measured by quantitative reverse transcriptase-PCR of its pre-mRNA levels.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
184736
Name
Yan Matthew S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The role of PRC2 and H3K27 methylation in eNOS repression
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Chromatin Immunoprecipitation; Endothelial Cells; Gene Repression; Histone H3k27 Trimethylation; Hypoxia; Polycomb Repressive Complex 2; Quantitative Rt-Pcr
Abstract
Dysregulated repressive transcriptional mechanisms can alter endothelial cell (EC)-specific gene expression in ECs and non-ECs to possibly cause disease states. Abnormal EC-specific gene expression might cause vasculogenic mimicry, a phenomenon in which aggressive melanoma cells adopt an "EC-like" phenotype to siphon blood flow to itself. Hypoxia (<1% O2) elicits endothelial dysfunction, in part, by transcriptionally repressing eNOS, an EC-specific gene. Deeper understanding of the repressive mechanisms regulating EC-specific gene expression can improve our therapeutic potential against such disease states. Our lab (the Marsden Lab)has found that the EC-specific expression of eNOS is regulated by epigenetic pathways associated with transcription activation, such as histone acetlyation and histone H3K4 methylation, and transcription repression, such as DNA methylation. Interestingly, our studies on eNOS epigenetic repression in non-expressing human aortic vascular smooth muscle cells (AoVSMCs) and chronically hypoxic (24 hours) human umbilical vein endothelial cells (HUVECS) suggest that it is regulated by additional repressive mechanisms. We hypothesize that histone H3K27 methylation and its mediator, polycomb repressive complex 2 (PRC2), epigenetically silence eNOS in non-expressing AoVSMCs and chronically hypoxic ECs. To test this, we will determine if histone H3K27 methylation and PRC2 subunits, such as the Ezh2 H3K27 methyltransferase, are enriched at the eNOS promoter in AoVSMCs and chronically hypoxic HUVECs by conducting chromatin immunoprecipitation assays. If AoVSMCs and chronically hypoxic HUVECs are enriched with trimethylated H3K27 and Ezh2 at the eNOS promoter, Ezh2 will be depleted by siRNA in these cells and eNOS transcriptional activity will be measured by quantitative reverse transcriptase-PCR of its pre-mRNA levels.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yan, Matthew S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~